Animal Vaccines Market Size Worth USD 34.76 Billion in 2032 | Emergen Research

The global animal vaccines market size was USD 13.90 Billion in 2022 and is expected to register a revenue CAGR of 9.7% during the forecast period. The global animal vaccines market is experiencing robust growth, driven by various factors including rising demand for pet insurance, increasing prevalence of animal diseases, and escalating animal health expenditure. A recent market research report highlights key drivers and trends shaping the landscape of the animal vaccines market.

Get Free Sample Report and Related Graphs & Charts @https://www.emergenresearch.com/request-sample/2807

Key Drivers:

1. Animal Health Expenditure: The surge in animal health expenditure is a significant contributor to the market's revenue growth. The adoption of advanced vaccines, such as BRAVECTO by Merck Animal Health, underscores the importance of preventive healthcare measures for animals.

2. Widespread Adoption of Ruminant Vaccines: With the increasing prevalence of diseases among cattle and expanding global livestock population, there is a growing demand for ruminant vaccines. These vaccines play a crucial role in ensuring the well-being of animals and maintaining the safety and quality of animal-derived products.

3. Importance of Animal Vaccines in Safeguarding Well-Being: Animal vaccines are vital in preventing the spread of infectious diseases and safeguarding the health of animals across diverse sectors within agriculture and commerce. They elicit immunity similar to natural defenses, contributing to disease control and prevention.

4. Increasing Population and Global Trade: The interconnectedness of global trade and travel, coupled with expanding populations of both humans and animals, creates opportunities for the transmission of pathogens. Animal vaccines play a crucial role in managing and controlling emerging health threats, including zoonotic diseases.

Market Restraints:

Adverse Impact on Human and Animal Health: Despite their benefits, veterinary vaccines may have adverse effects on human and animal health. Efforts such as the establishment of the U.K. Animal Vaccine Manufacturing and Innovation Centre aim to address these challenges and expedite vaccine development.

Request A Discount On The Report @https://www.emergenresearch.com/request-discount/2807

Segment Insights:

1. Animal Vaccines Product: The market is segmented into attenuated live vaccines, inactivated vaccines, subunit vaccines, DNA vaccines, and recombinant vaccines. The dominance of attenuated live vaccines reflects their efficacy in triggering immune responses and reducing mortality rates among animals.

2. Animal Vaccines Type: The market segments include livestock and companion animals. The livestock segment dominates due to factors such as expanding livestock population and occurrence of diseases. However, the companion segment is expected to register rapid growth, driven by the need for preventive vaccination among pets.

3. Animal Vaccines Route of Administration: Subcutaneous administration holds the largest market share, attributed to its convenience, swiftness, and minimal discomfort for animals. Intramuscular and intranasal routes are also commonly used for administering vaccines to animals.

The animal vaccines market is poised for significant growth driven by increasing awareness of preventive healthcare measures among pet owners, escalating animal health expenditure, and the need for disease control in livestock populations.

Animal Vaccines Top Companies and Competitive Landscape

The global animal vaccines market is fairly fragmented with many large and medium-sized players accounting for the majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, and developing, testing, and introducing more effective animal vaccines solutions.

• Zoetis
• Virbac
• Elanco
• Merck & Co., Inc.
• Ceva Santé Animale
• Boehringer Ingelheim International GmbH
• Phibro Animal Health Corporation
• IDEXX
• HESTER BIOSCIENCES LIMITED
• Indian Immunologicals Ltd.

Animal Vaccines Latest Industry News

• In September 2022, Zoetis acquired Jurox, a privately held animal health company that develops, manufactures, and markets a wide range of veterinary medicines for treating livestock and companion animals.

• In June 2022, Boehringer Ingelheim and CarthroniX partnered to pursue small-molecule therapeutics in canine oncology.

• In July 2021, Elanco acquired Kindred Bio, a biopharmaceutical company focused on developing novel pet therapeutics.

Request Customization Of The Report @https://www.emergenresearch.com/request-for-customization/2807

Animal Vaccines Segment Analysis

For the purpose of this report, Emergen Research has segmented the global animal vaccines market on the basis of product, type, route of administration, and region:

• Product Outlook (Revenue, USD Billion; 2019-2032)
o Attenuated live vaccines
o Inactivated vaccines
o Subunit vaccines
o DNA vaccines
o Recombinant vaccines

• Type Outlook (Revenue, USD Billion; 2019-2032)
o Livestock
o Companion

• Route of Administration Outlook (Revenue, USD Billion; 2019-2032)
o Subcutaneous
o Intramuscular
o Intranasal

• Regional Outlook (Revenue, USD Billion; 2019-2032)
o North America
1. U.S.
2. Canada
o Europe
1. Germany
2. France
3. U.K.
4. Italy
5. Spain
6. Benelux
7. Russia
8. Rest of Europe
o Asia Pacific
1. China
2. Japan
3. South Korea
4. India
5. ASEAN Countries
6. Oceania
7. Rest of APAC
o Latin America
1. Brazil
2. Mexico
3. Rest of LATAM
o Middle East & Africa
1. GCC Countries
2. Israel
3. Turkey
4. South Africa Rest of MEA

Click here to Buy Now @https://www.emergenresearch.com/select-license/2807

Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

This release was published on openPR.